Selection Bias When Estimating Average Treatment Effects Using One-sample Instrumental Variable Analysis.


Journal

Epidemiology (Cambridge, Mass.)
ISSN: 1531-5487
Titre abrégé: Epidemiology
Pays: United States
ID NLM: 9009644

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 22 3 2019
medline: 1 10 2019
entrez: 22 3 2019
Statut: ppublish

Résumé

Participants in epidemiologic and genetic studies are rarely true random samples of the populations they are intended to represent, and both known and unknown factors can influence participation in a study (known as selection into a study). The circumstances in which selection causes bias in an instrumental variable (IV) analysis are not widely understood by practitioners of IV analyses. We use directed acyclic graphs (DAGs) to depict assumptions about the selection mechanism (factors affecting selection) and show how DAGs can be used to determine when a two-stage least squares IV analysis is biased by different selection mechanisms. Through simulations, we show that selection can result in a biased IV estimate with substantial confidence interval (CI) undercoverage, and the level of bias can differ between instrument strengths, a linear and nonlinear exposure-instrument association, and a causal and noncausal exposure effect. We present an application from the UK Biobank study, which is known to be a selected sample of the general population. Of interest was the causal effect of staying in school at least 1 extra year on the decision to smoke. Based on 22,138 participants, the two-stage least squares exposure estimates were very different between the IV analysis ignoring selection and the IV analysis which adjusted for selection (e.g., risk differences, 1.8% [95% CI, -1.5%, 5.0%] and -4.5% [95% CI, -6.6%, -2.4%], respectively). We conclude that selection bias can have a major effect on an IV analysis, and further research is needed on how to conduct sensitivity analyses when selection depends on unmeasured data.

Identifiants

pubmed: 30896457
doi: 10.1097/EDE.0000000000000972
pmc: PMC6525095
mid: EMS81527
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

350-357

Subventions

Organisme : Medical Research Council
ID : MC\_UU\_00011/3
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC\_UU\_00011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/3
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Références

Int J Epidemiol. 2000 Aug;29(4):722-9
pubmed: 10922351
Epidemiology. 2004 Sep;15(5):615-25
pubmed: 15308962
Epidemiology. 2006 Jul;17(4):360-72
pubmed: 16755261
Stat Med. 2008 Apr 15;27(8):1133-63
pubmed: 17886233
BMC Med Res Methodol. 2008 Oct 30;8:70
pubmed: 18973665
Int J Epidemiol. 2010 Apr;39(2):417-20
pubmed: 19926667
Stat Methods Med Res. 2013 Jun;22(3):278-95
pubmed: 21220355
Stat Med. 2011 May 20;30(11):1312-23
pubmed: 21432888
Am J Epidemiol. 2012 Feb 15;175(4):332-9
pubmed: 22247045
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
Epidemiology. 2013 May;24(3):363-9
pubmed: 23532055
Epidemiology. 2013 May;24(3):370-4
pubmed: 23549180
Int J Epidemiol. 2013 Aug;42(4):1012-4
pubmed: 24062287
Stat Med. 2014 Jun 15;33(13):2297-340
pubmed: 24599889
Comput Stat Data Anal. 2010 Oct 1;54(10):2267-2275
pubmed: 24748700
Am J Epidemiol. 2015 Feb 1;181(3):191-7
pubmed: 25609096
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Am J Epidemiol. 2015 Oct 15;182(8):730-6
pubmed: 26429998
Int J Biostat. 2016 May 1;12(1):219-32
pubmed: 27227722
Epidemiology. 2017 May;28(3):396-398
pubmed: 28169934
Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):357-367
pubmed: 28239929
Am J Epidemiol. 2017 Jun 15;185(12):1233-1239
pubmed: 28338946
Epidemiology. 2017 Jul;28(4):553-561
pubmed: 28346267
Am J Epidemiol. 2017 Jun 1;185(11):1048-1050
pubmed: 28535177
Epidemiology. 2017 Sep;28(5):653-659
pubmed: 28590373
Am J Epidemiol. 2017 Nov 1;186(9):1026-1034
pubmed: 28641372
Curr Epidemiol Rep. 2017;4(4):281-287
pubmed: 29226066
Sociol Methods Res. 2017 Mar;46(2):155-188
pubmed: 30174355
Int J Epidemiol. 2018 Oct 15;:null
pubmed: 30325422
Nat Hum Behav. 2018 Feb;2(2):117-125
pubmed: 30406209
Stat Med. 1998 Feb 15;17(3):269-302; discussion 387-9
pubmed: 9493255
Epidemiology. 1999 Jan;10(1):37-48
pubmed: 9888278

Auteurs

Rachael A Hughes (RA)

From the Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.

Neil M Davies (NM)

From the Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.

George Davey Smith (G)

From the Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.

Kate Tilling (K)

From the Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH